发明授权
US08217044B2 Spiroindolinone pyrrolidines 失效
螺吲哚啉酮吡咯烷

Spiroindolinone pyrrolidines
摘要:
There are provided compounds of the formula wherein X, Y and R1 to R8 are as described herein and the enantiomers and pharmaceutically acceptable salts and esters thereof which compounds have anticancer activity.
公开/授权文献
信息查询
0/0